Biodexa Pharmaceuticals Plc

NasdaqCM:BDRX Stock Report

Market Cap: US$3.2m

Biodexa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BDRX?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme50.000114%
Individual Insiders2400.00547%
Hedge Funds222,7635.08%
VC/PE Firms273,4926.24%
Institutions338,6237.72%
Public Companies354,4338.08%
Private Companies552,47612.6%
General Public2,642,96460.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1753.5%.


Top Shareholders

Top 25 shareholders own 39.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.08%
Melior Pharmaceuticals, Inc
354,428US$256.9k0%no data
8.08%
Bukwang Pharmaceutical Co., Ltd.
354,428US$256.9k0%no data
6.24%
Mercer Street Capital Partners, LLC
273,492US$198.2k0%51.1%
5.08%
Bigger Capital, LLC
222,763US$161.5k0%1.89%
4.86%
District 2 Capital LP
213,081US$154.4k0%1.67%
3.6%
GS Capital Partners LLC
157,710US$114.3k0%no data
1.02%
Boothbay Fund Management, LLC
44,593US$32.3k0%no data
0.89%
Ionic Ventures, LLC
38,970US$28.2k0%no data
0.57%
Armistice Capital LLC
24,951US$18.1k7.21%no data
0.27%
Haitong International Asset Management (HK) Ltd.
12,055US$8.7k0%no data
0.27%
Renaissance Technologies LLC
11,700US$8.5k0%no data
0.25%
GAMMA Investing LLC
11,101US$8.0k972%no data
0.15%
Shamir Capital
6,551US$4.7k0%0.2%
0.12%
Bank of America Corporation, Asset Management Arm
5,236US$3.8k0%no data
0.063%
Cavalry Fund I Management, LLC
2,768US$2.0k0%0.24%
0.034%
Jarvis Securities plc, Asset Management Arm
1,470US$1.1k0%no data
0.031%
Anson Group
1,354US$981.40%no data
0.015%
A&B (HK) Company Limited
649US$470.40%no data
0.015%
Treasure Sea Limited
649US$470.40%no data
0.014%
UBS Asset Management AG
612US$443.7637%no data
0.011%
Rhumbline Advisers Ltd Partnership
498US$361.0123%no data
0.0098%
Walleye Capital LLC
429US$310.80%no data
0.0085%
A J Bell Holdings Limited, Asset Management Arm
373US$270.50%no data
0.0083%
Turner Pope Investments (TPI) Ltd, Asset Management Arm
364US$263.80%0.05%
0.0072%
Barclays Bank PLC, Wealth and Investment Management Division
314US$227.60%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.